Market research and growth strategy firm, Frost & Sullivan, has awarded Rousselot with the 2013 Global Product Line Strategy Award in the collagen peptides market, for its innovative Peptan range.
Each year, Frost & Sullivan recognises companies in a variety of markets for demonstrating outstanding performance in areas such as business growth, technical innovation, customer service, and product development.
For the Product Line Strategy Award, the criteria included breadth of product line; size of addressable customer base; impact on customer value; market share; and extent of applications and markets served.
Frost & Sullivan awarded the Global Product Line Strategy Award to Rousselot due to the unrivalled product offering, extensive customer support and proven efficacy of its Peptan range.
Peptan are highly digestible and bioactive peptides which provide various functional properties not found in other protein sources. Numerous studies have highlighted the ingredient's ability to promote healthy bones and joints, while collagen peptides have also been proven to increase muscle regeneration. Clinical research has also shown Peptan's ability to rejuvenate skin collagen structure and promote younger looking skin. Peptan can be easily and cost-effectively incorporated into a wide range of functional foods, beverages and nutraceutical.
Christopher J. Shanahan, global program manager for food & agriculture, at Frost & Sullivan, said: "As the clear market leaders and innovators within the collagen peptides category, we are proud to present Rousselot with the 2013 Product Line Strategy Award."
Hans Langereis, vice president global sales & marketing, Rousselot, added: "It is with great pleasure that we accept this prestigious accolade from Frost & Sullivan. Not only does the award recognise the ongoing investments we make in our ingredients portfolio and technical capabilities, it is also an invaluable endorsement of our customer-centric, science-led approach to product development."